Coordinated TNF–NF‐κB and PI3K–Akt Modulation by Yueju Pill in Hashimoto's Thyroiditis: A Network Pharmacology and Molecular Docking Study
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hao Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Anhui University of Chinese Medicine, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, NF-kappa B. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Clinical Medicine Research Transformation Project of 2025, Anhui Provincial Health and Health Research Project.
Abstract (Originalsprache)
To predict the polypharmacological mechanism of Yueju pill (YJP) against Hashimoto's thyroiditis (HT), this study integrated network pharmacology and molecular docking to develop a computationally derived “dual‐axis core” hypothesis involving the TNF–NF‐κB inflammatory axis and the PI3K–Akt survival/apoptosis axis. Candidate active compounds and putative targets were identified, followed by PPI network construction and GO and KEGG enrichment analyses. Representative compounds were further evaluated by molecular docking, with redocking and reference–ligand comparisons used to assess docking reliability. A total of 167 common drug–disease targets were identified, from which 13 hub targets were screened. Enrichment analysis highlighted the TNF, PI3K–Akt, IL‐17, Th17 cell differentiation, and apoptosis‐related pathways. Quercetin, luteolin, kaempferol, and wogonin showed predicted interactions with multiple inflammation‐ and apoptosis‐related targets. Redocking reproduced crystallographic binding modes for CASP3, IKBKB, MAPK1, and AKT1 with RMSD values below 2.0 Å. Overall, the integrated computational analyses support a testable “dual‐axis core” hypothesis in which YJP may coordinately modulate inflammatory and survival/apoptosis‐related signaling in HT, providing prioritized targets and a mechanistic framework for future experimental validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Anhui University of Chinese Medicine, Hefei, Anhui, China.
- Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
- Breast Cancer Center, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Breast Cancer Center, Anhui Provincial Cancer Hospital, Hefei, Anhui, China.
ORCID-Profile: Hao Zhang, Kuojun Ren, Shengying Wang
Förderung
- Anhui Provincial Clinical Medicine Research Transformation Project of 2025
- Anhui Provincial Health and Health Research Project
Zitieren
APA
Zhang, H., Ren, K., & Wang, S. (2026). Coordinated TNF–NF‐κB and PI3K–Akt Modulation by Yueju Pill in Hashimoto's Thyroiditis: A Network Pharmacology and Molecular Docking Study. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71790
Vancouver
Zhang H, Ren K, Wang S. Coordinated TNF–NF‐κB and PI3K–Akt Modulation by Yueju Pill in Hashimoto's Thyroiditis: A Network Pharmacology and Molecular Docking Study. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71790
BibTeX
@article{Zhang2026,
author = {Zhang, Hao and Ren, Kuojun and Wang, Shengying},
title = {Coordinated TNF–NF‐κB and PI3K–Akt Modulation by Yueju Pill in Hashimoto's Thyroiditis: A Network Pharmacology and Molecular Docking Study},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71790}
}
EUVIMED